BILLS-109hr4395ih.pdf

4395 IH annual 2003 January 1, 2006 a year 2005 the year monthly the month 2006 22 year 1853 each year quarterly 19 2003 7 days 1 year 7 day 5-year 6 year 1996 fiscal year 2006 July 1, 2006 2007 2008 42 U.S.C. 9902(2 3 week 1854 2-year the first calendar quarter 2 year 1ST SESSION H. R. 4395 a quarter 14 year 1991 1-year 2 years 1841 the 3 months in the quarter the previous year a year after 2006 annually 30 days 5 year NOVEMBER 18, 2005 4) DATE such quarter the quarter years

section 1838(b the ‘‘Pharmaceutical 9 XVIII NAIC Model Regulation

United States XVIII the United States the District of Columbia the United States of America States MA

appro- 12 appro- 19 PHARMACIES.—Each 17

D. American Americans APPROPRIATIONS.—To NECESSARY.—Each

SEC State MA Medicare U.S.C. Committee Congress Prescription Drug Trust Fund the Task Force MedicareAdvantage Food, Drug GENERAL.—If Drug, Improvement the Federal Food, Drug the Federal Food Federal Medicare Senate the Centers for Medicare & Medicaid Federal Medicare Prescription Drug Trust Fund NAIC Prescription Drug Advisory Committee Health and Human Services Commission 104 the Food and Drug Administration the Federal Medicare QUIRED Science XIX Office Medicare Payment Advisory Commission the Committee on Commerce uct the Federal Government Pharmaceutical ECONOMICS OF DRUG MARKET THE HOUSE OF REPRESENTATIVES the ‘Committee’ Drug Bureau Quality Control and Cost Containment Blue Ribbon Task Force the Committee on Energy the Committee on Commerce, Science PATION STAFF.—The Committee FUNCTIONS OF COMMITTEE.—The Committee

DOWN.—In CONYERS XVIII

drug benefit prescription drug prescription medicare medicare prescription drug voluntary outpatient drugs manufacturers prescription drugs prices counterfeit affordable benefit